Mirexus, a biomaterials spinout of Guelph, will use the funding to support a new production facility.

The antibody replacement technology was co-developed by the California Institute of Technology.

Merck unit M Ventures co-led an $11.5m round for the antibody replacement technology developer with corporate-sponsored firm Legend Capital.

The Manchester spinout is seeking capital to launch its first product, a test that can detect the early-stage onset of an eye disease called age-related macular degeneration.

Existing investor Novo Ventures contributed to a series C round announced alongside Unchained Labs' acquisition of protein measurement device maker Trinean.

Frontier IP has received a 20% stake in Molendotech, a new spinout of Plymouth University that has developed a way to test the purity of water.

The pharmaceutical company has bought diabetes management platform MySugr for an undisclosed sum, two years after its corporate venturing unit backed a $4.8m seed round.

The fund, first announced in October 2016, has been launched with $10m in capital to invest in spinouts and startups that emerge from the university or surrounding region.

The bone disease therapy developer had raised $92.5m from investors including UCB Pharma across two rounds in 2015.

The company has licensed the platform of University College London spinout Nanogenics to develop a cancer treatment.